Lectrix and Orbweaver announce the launch of AI tools Lassie and Laifae, developed with OpenAI and built directly into its infrastructure.
T-cell therapy has revolutionised the treatment of B-cell malignancies, offering durable responses for patients with relapsed or refractory disease. However, access globally remains limited due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback